| INSR |
INSR: Insulin receptor precursor |
NOS2A |
NOS2A, NOS2: Nitric oxide synthase, inducible |
0.41 |
Evidence |
|
| JUN |
JUN: Transcription factor AP-1 |
C1QBP |
C1QBP, GC1QBP, HABP1, SF2P32: Complement component 1 Q subcomponent-binding prot |
0.41 |
Evidence |
|
| JUN |
JUN: Transcription factor AP-1 |
PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
0.41 |
Evidence |
|
| EIF2S1 |
EIF2S1, EIF2A: Eukaryotic translation initiation factor 2 subunit 1 |
PSEN1 |
PSEN1, AD3, PS1, PSNL1: Presenilin-1 |
0.41 |
Evidence |
|
| ATP1A1 |
ATP1A1: Sodium/potassium-transporting ATPase subunit alpha-1 precursor |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
0.41 |
Evidence |
|
| ATP1A1 |
ATP1A1: Sodium/potassium-transporting ATPase subunit alpha-1 precursor |
NR4A2 |
NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 |
0.41 |
Evidence |
|
| ATP1A1 |
ATP1A1: Sodium/potassium-transporting ATPase subunit alpha-1 precursor |
JUN |
JUN: Transcription factor AP-1 |
0.41 |
Evidence |
|
| TP53 |
TP53, P53: Cellular tumor antigen p53 |
PSEN1 |
PSEN1, AD3, PS1, PSNL1: Presenilin-1 |
0.41 |
Evidence |
|
| ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
NOS2A |
NOS2A, NOS2: Nitric oxide synthase, inducible |
0.41 |
Evidence |
|
| FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
PTPN2 |
PTPN2, PTPT: Tyrosine-protein phosphatase non-receptor type 2 |
0.41 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
CLTC |
CLTC, CLH17, CLTCL2, KIAA0034: Clathrin heavy chain 1 |
0.41 |
Evidence |
|
| EGFR |
EGFR, ERBB1: Epidermal growth factor receptor precursor |
MYF5 |
MYF5: Myogenic factor 5 |
0.41 |
Evidence |
|
| CHEK2 |
CHEK2, CHK2, RAD53: Serine/threonine-protein kinase Chk2 |
KDR |
KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor |
0.41 |
Evidence |
|
| ATRN |
IPI00027235 |
CHEK2 |
CHEK2, CHK2, RAD53: Serine/threonine-protein kinase Chk2 |
0.41 |
Evidence |
|
| EDF1 |
EDF1: Endothelial differentiation-related factor 1 |
GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
0.41 |
Evidence |
|
| EDF1 |
EDF1: Endothelial differentiation-related factor 1 |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
0.41 |
Evidence |
|
| SORBS3 |
SORBS3, SCAM1: Vinexin |
RAD18 |
RAD18, RNF73: E3 ubiquitin-protein ligase RAD18 |
0.41 |
Evidence |
|
| DLX3 |
DLX3: Homeobox protein DLX-3 |
GRIN2A |
GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor |
0.41 |
Evidence |
|
| DLX3 |
DLX3: Homeobox protein DLX-3 |
GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
0.41 |
Evidence |
|
| FIGF |
FIGF, VEGFD: Vascular endothelial growth factor D precursor |
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
0.41 |
Evidence |
|
| AKAP8 |
AKAP8, AKAP95: A-kinase anchor protein 8 |
PSEN1 |
PSEN1, AD3, PS1, PSNL1: Presenilin-1 |
0.41 |
Evidence |
|
| KCNQ2 |
KCNQ2: Potassium voltage-gated channel subfamily KQT member 2 |
RELA |
RELA, NFKB3: Transcription factor p65 |
0.41 |
Evidence |
|
| FOXO3A |
FOXO3A, FKHRL1: Forkhead box protein O3A |
ACVR1B |
ACVR1B, ACVRLK4: Activin receptor type-1B precursor |
0.41 |
Evidence |
|
| ADCY6 |
ADCY6, KIAA0422: Adenylate cyclase type 6 |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
0.41 |
Evidence |
|
| ADCY6 |
ADCY6, KIAA0422: Adenylate cyclase type 6 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
0.41 |
Evidence |
|